TY - JOUR
T1 - Ischemic Hepatitis in a Patient with Congestive Cardiomyopathy
T2 - An Innovative Approach to Therapy Using Intravenous Dobutamine
AU - Levy, Daniel K.
AU - Schwartz, Jonathan M.
AU - Frishman, William H.
AU - Schwarz, Michael L.
AU - LeJemtel, Thierry H.
PY - 1994/3
Y1 - 1994/3
N2 - Patients who sustain a transient period of hypotension or low cardiac output can develop massive elevations of the serum transaminases without serum markers of acute hepatitis, a recent myocardial infarction or exposure to toxins and chemicals. This condition is often termed “ischemic hepatitis” (IH), with its pathological correlate being centrilobular necrosis. Recognition of IH can help in the appropriate management of these patients, and avoid unnecessary diagnostic testing. The authors describe a patient with congestive cardiomyopathy in whom IH developed as part of a complicated hospital course. The condition appeared to reverse with the administration of dobutamine, suggesting inotropic therapy as an appropriate treatment modality. 1994 American College of Clinical Pharmacology
AB - Patients who sustain a transient period of hypotension or low cardiac output can develop massive elevations of the serum transaminases without serum markers of acute hepatitis, a recent myocardial infarction or exposure to toxins and chemicals. This condition is often termed “ischemic hepatitis” (IH), with its pathological correlate being centrilobular necrosis. Recognition of IH can help in the appropriate management of these patients, and avoid unnecessary diagnostic testing. The authors describe a patient with congestive cardiomyopathy in whom IH developed as part of a complicated hospital course. The condition appeared to reverse with the administration of dobutamine, suggesting inotropic therapy as an appropriate treatment modality. 1994 American College of Clinical Pharmacology
UR - http://www.scopus.com/inward/record.url?scp=0028208803&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028208803&partnerID=8YFLogxK
U2 - 10.1002/j.1552-4604.1994.tb03998.x
DO - 10.1002/j.1552-4604.1994.tb03998.x
M3 - Article
C2 - 8021337
AN - SCOPUS:0028208803
SN - 0091-2700
VL - 34
SP - 270
EP - 272
JO - The Journal of Clinical Pharmacology
JF - The Journal of Clinical Pharmacology
IS - 3
ER -